Holen Sie sich die Stockscreener-App
96.78
1.33%
1.27
Vorhandelsmarkt:
98.00
1.22
+1.26%
Schlusskurs vom Vortag:
$95.51
Offen:
$95.51
24-Stunden-Volumen:
396.29K
Relative Volume:
0.99
Marktkapitalisierung:
$1.61B
Einnahmen:
$5.82B
Nettoeinkommen (Verlust:
$-373.54M
KGV:
-4.2926
EPS:
-22.546
Netto-Cashflow:
$-87.01M
1W Leistung:
+2.84%
1M Leistung:
-15.73%
6M Leistung:
+759.31%
1J Leistung:
+343.13%
1-Tages-Spanne:
$94.56
$103.88
1-Wochen-Bereich:
$86.29
$114.32
52-Wochen-Spanne:
$7.48
$133.04
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, EHC, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
96.78 | 1.64B | 5.82B | -373.54M | -87.01M | -22.55 |
HCA
Hca Healthcare Inc
|
414.03 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
259.93 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
24.35 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
125.81 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
183.69 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
AGL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
agilon health inc (AGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
agilon health inc (AGL) Balance Sheet - TradingKey
agilon health inc (AGL) Cash Flow - TradingKey
AGL|agilon health inc|Price:98.000|Chg%:-2.450 - TradingKey
AGL|agilon health inc|Price:98.430| - TradingKey
What Does the New CEO Appointment Mean for Agilon Health (AGL) - Kavout | AI
agilon health, inc. (AGL) Stock Price, News, Quote & History - Yahoo! Finance Canada
AGL Downgraded by Citigroup -- Price Target Raised to $105 - GuruFocus
agilon health inc (AGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
agilon health, inc. Stock 12‑Month Price Target Raised to $73.36, Implies 39% Downside - TradingView
Why agilon health (AGL) Shares Are Falling Today - Yahoo Finance
Citi Downgrades Agilon Health(AGL.US) to Sell Rating, Raises Target Price to $105 - Moomoo
Citigroup Downgrades Agilon health to Sell From Neutral, Adjusts Price Target to $105 From $80 - marketscreener.com
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Agilon Health | 8-K: Current report - Moomoo
Why Is AGL Stock Rising Today? - Stocktwits
Agilon health, inc. Announces Termination of Girish Venkatachaliah as Chief Technology Officer, Effective August 1, 2026 - marketscreener.com
Agilon Health Announces CTO Transition and Consulting Role - TipRanks
agilon CTO Girish Venkatachaliah to Depart Aug 1, 2026 with Severance and Consulting Arrangement - TradingView
AGL stock holds as Agilon Health revenue and loss frame the 2026 outlook - Ad-hoc-news.de
agilon health inc. (AGL) Q1 2026 Earnings: EPS Surges Past Estimates Amidst Market SkepticismEarnings Manipulation Risk - dars.gov.et
agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a -41.38% Potential Downside - DirectorsTalk Interviews
Agilon Health (NYSE:AGL) Stock Price Down 5%Time to Sell? - MarketBeat
agilon health (AGL) Proxy filing Summary - Quartr
Timothy Patrick O'rourke Net Worth (2026) - GuruFocus
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $141 - Moomoo
Agilon health stock hits 52-week high at 126.0 USD By Investing.com - Investing.com South Africa
Agilon health stock hits 52-week high at 126.0 USD - Investing.com
The Bull Case For agilon health (AGL) Could Change Following Strong 2024 REACH ACO Savings And Quality - Sahm
Price to book forward of agilon health, inc. – NYSE:AGL - TradingView
Price to book forward of agilon health, inc. – BOATS:AGL - TradingView
agilon health ACOs achieve $229M in savings under Medicare program - Investing.com India
AGL stock steadies as Agilon Health follows its care model - Ad-hoc-news.de
Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4% - TradingView
agilon health ACOs achieve $229M in savings under Medicare program By Investing.com - Investing.com South Africa
agilon health Reports ACO REACH Model Results for 2024 Performance Year - Business Wire
Barclays Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Press Release: Agilon Health Sets Date to Report Second Quarter 2026 Financial Results - 富途牛牛
agilon health Sets Date to Report Second Quarter 2026 Financial Results - Business Wire
agilon health sets Aug. 5 call for second-quarter results - Stock Titan
How Investors Are Reacting To agilon health (AGL) Scrutiny On Value-Based Medicare Advantage Execution - Yahoo Finance
Agilon Health stock stays tied to Medicare Advantage trends. - Ad-hoc-news.de
Deutsche Bank upgrades agilon health stock rating on raised guidance - Investing.com
Jefferies upgrades agilon health stock rating on rate visibility - Investing.com
AGL STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Agilon Health (NYSE:AGL) Faces A Value Care Test - Kalkine Media
Form 4 agilon health Inc For: 2 July By Investing.com - Investing.com Nigeria
CFO of agilon health (AGL) uses 2,311 shares to cover RSU taxes - Stock Titan
Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) - The National Law Review
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Agilon Health Inc-Aktie (AGL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wulf John William | Director |
Nov 12 '25 |
Buy |
0.63 |
81,000 |
50,941 |
365,857 |
9.78%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):